Belite Bio Incorporation Aktie
    Aktie
    ISIN: US07782B1044 WKN: A3DKYL SYM: D01 Land Flagge KY Kaiman-Inseln
    Zur Watchlist hinzufügenZur Watchlist hinzufügen Zum Portfolio hinzufügenZum Portfolio hinzufügen
    46,20
     
    EUR
    +2,21 %
    +1,00 EUR
    Letzter Kurs 04.10.24 Frankfurt
    Geldkurs
    04.10.24
    46,00
     
    EUR
    180 STK
    Briefkurs
    04.10.24
    46,60
     
    EUR
    180 STK

    Belite Bio Incorporation Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
    10.09.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Participate in Three Upcoming Investor Conferences
    03.09.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
    01.09.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
    09.08.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
    08.08.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
    06.08.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Present at the JonesHealthcare Seaside Summit
    08.07.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
    12.06.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
    14.05.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
    14.05.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    13.05.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht
    Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
    08.05.24 · globenewswire · Belite Bio IncorporationEnglische Nachricht